Abeterno Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Liquidation

Abeterno General Information

Description

Developer of research tools for cell separation and live cell imaging. The company's research tools have developed novel cell isolation technology that makes use of magnetic nanoparticles to purify live cells using intracellular proteins.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Cambridge
  • England, United Kingdom
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Cambridge
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abeterno Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 01-Feb-2017 Completed Bankruptcy: Liquidation
1. Seed Round Completed Startup
To view Abeterno’s complete valuation and funding history, request access »

Abeterno Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Abeterno Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201417809-D0 Nanoparticles Inactive 08-Oct-2014
GB-201306589-D0 Live cell imaging Inactive 11-Apr-2013
GB-2525825-A In vivo cell imaging Inactive 11-Apr-2013
US-20160045622-A1 In vivo cell imaging Inactive 11-Apr-2013
GB-201516123-D0 In vivo cell imaging Inactive 11-Apr-2013 A61K49/0093
To view Abeterno’s complete patent history, request access »

Abeterno Executive Team (2)

Name Title Board Seat
Michael McLean Ph.D Board Member & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Abeterno Board Members (3)

Name Representing Role Since
Linda Cammish Ph.D Self Board Member
Michael McLean Ph.D Self Board Member & Chief Executive Officer
You’re viewing 2 of 3 board members. Get the full list »

Abeterno Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Abeterno FAQs

  • When was Abeterno founded?

    Abeterno was founded in 2011.

  • Who is the founder of Abeterno?

    Rosalind Codrington Ph.D is the founder of Abeterno.

  • Who is the CEO of Abeterno?

    Michael McLean Ph.D is the CEO of Abeterno.

  • Where is Abeterno headquartered?

    Abeterno is headquartered in Cambridge, United Kingdom.

  • What is the size of Abeterno?

    Abeterno has 2 total employees.

  • What industry is Abeterno in?

    Abeterno’s primary industry is Biotechnology.

  • Is Abeterno a private or public company?

    Abeterno is a Private company.

  • What is Abeterno’s current revenue?

    The current revenue for Abeterno is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »